10 at 10: These 10 ASX stocks are looking primed for the rebound this morning
Link copied to
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
Despite today being a day when many stocks have rallied (849 ASX stocks are up while only 77 are down and the rest are unchanged), there’s still no better news than announcing you’re taking the coronavirus head on.
Digital health play Lifespot Health (ASX:LSH) announced it was expanding its platform to help track fevers as a result of the epidemic.
Cancer fighting biotech Amplia Therapeutics (ASX:ATX) climbed too with news the FDA granted its drug Orphan Drug designation.
|BOT||Botanix Pharmaceuticals Ltd||0.03||-61.19%||13.6M|
|ANL||Amani Gold Ltd||0.001||-50.00%||300.0k|
|NWE||Norwest Energy NL||0.002||-33.33%||500.0k|
|APH||Australian Primary Hemp Ltd||0.05||-24.24%||108.9k|
|AVE||Avecho Biotechnology Ltd||0.002||-20.00%||429.0k|
|NWC||New World Resources Ltd||0.005||-16.67%||10.6k|
|BKT||Black Rock Mining Ltd||0.03||-10.34%||19.3k|
|SGF||SG Fleet Group Ltd||1.05||-7.89%||46.5k|
On the flip side Botanix Pharmaceuticals (ASX:BOT) plunged after a failed clinical trial.